AHCO
Company Description
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.24B | 3.26B | 3.20B | 2.97B | 2.45B | 1.06B | 529.64M | 345.28M | 192.56M | 174.32M |
| Net Income | (70.79M) | 90.42M | (678.89M) | 69.32M | 156.18M | (161.63M) | (21.34M) | 2.09M | (693) | (3.79M) |
| EPS | -0.52 | 0.62 | -5.32 | 0.52 | 1.12 | -1.23 | 0.17 | 0.07 | 0.00 | -0.12 |
| Free Cash Flow | 219.38M | 235.78M | 143.20M | (17.56M) | 72.37M | 155.88M | 39.09M | 58.48M | 39.08M | 27.47M |
| FCF / Share | 1.62 | 1.76 | 1.07 | -0.13 | 0.57 | 2.97 | 0.54 | 1.87 | 1.25 | 0.88 |
| Operating CF | 601.77M | 541.84M | 480.67M | 373.87M | 275.68M | 195.63M | 60.42M | 68.43M | 45.93M | 29.94M |
| Total Assets | 4.32B | 4.49B | 4.51B | 5.22B | 5.25B | 1.81B | 546.54M | 254.12M | 310,616 | N/A |
| Total Debt | 1.90B | 2.13B | 2.29B | 2.33B | 2.37B | 807.00M | 416.82M | 155.17M | 174,240 | N/A |
| Cash & Equiv | 106.14M | 109.75M | 77.13M | 46.27M | 149.63M | 99.96M | 76.88M | 947,098 | 119,821 | N/A |
| Book Value | 1.52B | 1.57B | 1.46B | 2.15B | 2.06B | 354.89M | (38.82M) | 245.55M | 24,307 | N/A |
| Return on Equity | -0.05 | 0.06 | -0.47 | 0.03 | 0.08 | -0.46 | N/A | 0.01 | -0.03 | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 819.80M | 846.29M | 602.63M | 591.81M | 580.47M | 856.64M | 597.55M | 595.03M | 594.10M | 1.48B | 583.68M | 583.62M |
| Net Income | (16.04M) | (102.77M) | 24.51M | 14.67M | (7.21M) | 50.26M | 22.86M | 19.43M | (2.13M) | (254.50M) | (454.08M) | 13.98M |
| EPS | -0.12 | -0.74 | 0.17 | 0.10 | -0.05 | 0.34 | 0.16 | 0.13 | -0.02 | -1.91 | -3.37 | 0.10 |
| Free Cash Flow | (27.49M) | 79.29M | 66.82M | 73.33M | (58,000) | 73.08M | 84.85M | 116.71M | (38.86M) | 66.62M | 21.75M | 3.71M |
| FCF / Share | -0.20 | 0.59 | 0.49 | 0.54 | -0.00 | 0.54 | 0.63 | 0.88 | -0.29 | 0.50 | 0.16 | 0.03 |
| Operating CF | 93.72M | 183.18M | 161.07M | 161.99M | 95.53M | 150.41M | 144.41M | 197.98M | 49.03M | 155.27M | 98.83M | 86.32M |
| Total Assets | 4.42B | 4.32B | 4.38B | 4.35B | 4.44B | 4.49B | 4.47B | 4.51B | 4.50B | 4.51B | 4.73B | 5.20B |
| Total Debt | 2.00B | 1.90B | 1.90B | 1.95B | 2.10B | 2.13B | 2.18B | 2.23B | 2.35B | 2.29B | 2.30B | 2.31B |
| Cash & Equiv | 47.96M | 106.14M | 80.36M | 68.63M | 53.65M | 109.75M | 100.18M | 69.83M | 79.57M | 77.13M | 56.14M | 45.13M |
| Book Value | 1.51B | 1.52B | 1.62B | 1.59B | 1.57B | 1.57B | 1.52B | 1.49B | 1.46B | 1.46B | 1.73B | 2.18B |
| Return on Equity | -0.01 | -0.07 | 0.02 | 0.01 | -0.00 | 0.03 | 0.02 | 0.01 | -0.00 | -0.17 | -0.26 | 0.01 |
